Sector Biotechnologies, Agri-food, Health
TREATMENT FOR PRE-DIABETES
Active substance developed to reduce the risk of type 2 diabetes
VALBIOTIS is a Research & Development company, committed to scientific innovation for the prevention and fight against metabolic diseases. The collaboration* with La Rochelle Université (LIENSs laboratory) has enabled the development of the active substance of plant origin TOTUM 63 to reduce the risk of type 2 diabetes. Today, VALBIOTIS is a listed company, which has succeeded in the industrial transposition of TOTUM-63 thanks to a collaboration with the Pierre Fabre Group and which signed a strategic development and marketing partnership with Nestlé Health Science at the beginning of 2020. A success story to which we are proud to have contributed! * The CNRS and the University of Clermont Auvergne
